Manufacturers/Piramal Critical Care

Piramal Critical Care

3 drugs in NADAC|3 Generic,0 Brand

View Recalls (3)

Piramal Critical Care lists 3 NDCs in the CMS NADAC file (3 generic, 0 brand), at an average NADAC of $1.37 per unit, with a week-over-week move of +3.2% across products that moved. The firm's full portfolio, pricing trend, and FDA recalls are listed below.

Total Drugs

3

3G / 0B

Avg Price / Unit

$1.3651

$0.39 – $2.37

Avg 7d Change

+3.22%

Across 1 drugs with changes

7d Activity

12 flat

of 3 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Frequently Asked Questions

How many drugs does Piramal Critical Care make?

Piramal Critical Care lists 3 NDCs in the CMS NADAC file — 3 generic and 0 brand products.

What is the average price of Piramal Critical Care drugs?

The average NADAC across Piramal Critical Care's portfolio is $1.3651 per unit, ranging from $0.3942 to $2.3740.

What types of drugs does Piramal Critical Care make?

Piramal Critical Care makes drugs across 4 FDA pharmacologic classes. The most common by NDC count are Proton Pump Inhibitor (1), Anticholinergic (1), Cholinergic Muscarinic Antagonist (1), Nondepolarizing Neuromuscular Blocker (1).

Has Piramal Critical Care had any drug recalls?

3 FDA recalls are matched to Piramal Critical Care in the openFDA feed, most recently on Sep 10, 2021.

How has Piramal Critical Care's pricing changed recently?

Over the past 7 days, 1 Piramal Critical Care product rose and 0 fell, with a portfolio-wide average change of +3.2%.

Drug Portfolio

3 drugs total, 3 shown

Drug Price 7d Change
PANTOPRAZOLE SODIUM 40 MG VIAL
PANTOPRAZOLE SODIUM
$2.3740
per EA
GLYCOPYRROLATE 0.2 MG/ML VIAL
Glycopyrrolate
$1.3269
per ML
+3.22%
ROCURONIUM 50 MG/5 ML VIAL
Rocuronium
$0.3942
per ML

FDA Recalls (3)

Recalls matched by company name. Verify current status with FDA.

D-0019-2022
Terminated
Class II

Rocuronium Bromide Injection 50mg/5 mL, 5mL Multi-Dose Vial, Rx only, Manufactured for: Piramal Critical Care, Bethlehem, PA 18017, USA, Manufactured by: Sanovel Ilac, San. Ve Tic. A.S. Istanbul, Turkey, NDC 66794-0228-41

Labeling: Label Lacks Warning or Rx Legend: Finished product did not include the statement on the flip cap vial, "WARNING: PARALYZING AGENT"

Initiated: 9/10/2021
D-1742-2019
Terminated
Class II

Gablofen (baclofen injection), 50 mcg/mL, Single Use Syringe, Rx only, packaged in a box containing one 1 mL syringe, Distributed by: Primal Critical Care, Inc., 3950 Schelden Circle Bethlehem, PA, 18017, NDC 66794-151-01

Failed Impurities/Degradation Specification -This recall is being initiated as a precaution due to the presence of an unknown impurity observed during shelf life of the product.

Initiated: 7/8/2019
D-1262-2014
Terminated
Class II

Sevoflurane, USP (Inhalation Anesthetic), Rx Only, 250 mL Amber Bottle. Manufactured By: Piramal Critical Care, 3950 Schelden Circle, Bethlehem, PA 18017. NDC: 66794-015-25.

Failed pH Specifications: product was too acidic.

Initiated: 4/7/2014